bw a868c has been researched along with 15-methylprostaglandin d2 in 1 studies
| Studies (bw a868c) | Trials (bw a868c) | Recent Studies (post-2010) (bw a868c) | Studies (15-methylprostaglandin d2) | Trials (15-methylprostaglandin d2) | Recent Studies (post-2010) (15-methylprostaglandin d2) |
|---|---|---|---|---|---|
| 47 | 0 | 11 | 6 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinemann, A; Peskar, BA; Prenn, C; Schuligoi, R | 1 |
1 other study(ies) available for bw a868c and 15-methylprostaglandin d2
| Article | Year |
|---|---|
CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Female; Hydantoins; Intestinal Secretions; Intestine, Small; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Receptors, Prostaglandin | 2008 |